Immunogen, Inc.

NASDAQ:IMGN   3:59:57 PM EDT
5.45
-0.07 (-1.27%)
Other Pre-Announcement

ImmunoGen Reports Q3 Loss Per Share $0.13

Published: 11/06/2020 11:47 GMT
ImmunoGen Inc (IMGN) - Immunogen Reports Recent Progress and Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.13.
Sees FY 2020 Revenue $60 Million to $65 Million.
Q3 Revenue $18.2 Million Versus Refinitiv Ibes Estimate of $15.4 Million.
Q3 Earnings per Share Estimate $-0.18 -- Refinitiv Ibes Data (analyst estimates).
Strengthened Balance Sheet Expected to Fund Operations Into Second Half of 2022.